Simplex Trading
SCPH

Simplex Trading’s scPharmaceuticals SCPH Stock Holding History

Simplex Trading’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,400
Closed -$8K – 9612
2025
Q1 		$8K Buy
3,400
+2,000
+143% +$6.51K ﹤0.01% 7263
2024
Q4 		$4K Sell
1,400
-20,500
-94% -$78.5K ﹤0.01% 7784
2024
Q3 		$99K Buy
21,900
+18,400
+526% +$89K ﹤0.01% 5244
2024
Q2 		$15K Sell
3,500
-7,500
-68% -$33K ﹤0.01% 7143
2024
Q1 		$55K Buy
11,000
+4,900
+80% +$27.4K ﹤0.01% 6184
2023
Q4 		$38K Buy
+6,100
New +$34.9K ﹤0.01% 6358
2023
Q3 		– Sell
-59,600
Closed -$607K – 9684
2023
Q2 		$607K Buy
59,600
+50,000
+521% +$522K ﹤0.01% 3106
2023
Q1 		$87K Buy
9,600
+3,600
+60% +$26.4K ﹤0.01% 5308
2022
Q4 		$43K Buy
+6,000
New +$36.7K ﹤0.01% 6065

Simplex Trading's SCPH Position: Q4 2025 in Review

Simplex Trading sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 6,504 shares — an estimated $36K sold.

Simplex Trading first reported a position in SCPH in Q4 2021 and held it in 11 quarters. The position peaked at $288K in Q2 2022. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

  • Simplex Trading reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 6,504 scPharmaceuticals shares in Q4 2025, an estimated $36K.
  • Simplex Trading first reported a position in scPharmaceuticals in Q4 2021 and held it in 11 quarters.
  • Simplex Trading's scPharmaceuticals position peaked at $288K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.